Enabling women with type 1 diabetes to achieve their goals with Automated Insulin Delivery
Chair: Helen Murphy (GBR) 11:30 – 11:45 mylife CamAPS FX : a unique solution while planning and throughout pregnancy Helen Murphy (GBR) 11:45 – 12:00 Application in the clinical practice : insights from a center initiating the journey with mylife CamAPS FX Pilar Beato Vibora (ESP) Friday, 13 September 2024 11:30 – 12:00 CEST Spotlight […]
Multidisciplinary dialogue on non-invasive liver assessment in patients with obesity: from guidelines to clinical research
Chair: Amalia Gastaldelli (ITA) 10:00 – 10:05 Introduction Amalia Gastaldelli (ITA) 10:05 – 10:10 Interplay between obesity and liver disease Onno Holleboom (NLD) 10:10 – 10:20 Guideline directed use of non-invasive tests (NITs) for liver assessment Jörn Schattenberg (DEU) 10:20 – 10:27 NITs and digital biomarkers for MASH diagnosis in clinical practice and research All […]
Management of CKD in T2D – where are we today?
Chairs: Paola Fioretto (ITA), Jose Luis Górriz (ESP) 19:45 – 19:46 Introduction Paola Fioretto (ITA) 19:46 – 19:48 Global burden of CKD and T2D Jose Luis Górriz (ESP) 19:48 – 19:52 Evolution of clinical guidelines in CKD and T2D Paola Fioretto (ITA) 19:52 – 19:55 Kidney outcome trials in people with CKD and T2D Jose […]
Cholesterol Lowering in High Cardiovascular Risk Patients with Comorbidities: Closing Gaps and Future Opportunities
Chair: Klaus Parhofer (DEU) 18:45 – 18:50 Welcome and introduction Klaus Parhofer (DEU) 18:50 – 19:00 LDL lowering in patients with diabetes and other metabolic diseases Luis Masana (ESP) 19:00 – 19:15 Unmet needs: Real-world evidence reveals treatment gaps in patients with diabetes and obesity Anna Solini (ITA) 19:15 – 19:30 Closing the Gap: Advancing […]
Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies
Chair: Meena Bansal (USA) 18:45 – 18:55 Introduction. The Growing Burden of MASLD/MASH: A Call to Action Meena Bansal (USA) 18:55 – 19:10 THR-β Agonists and Other Disease-specific Therapies Poised to Change the Paradigm Juan Pericàs (ESP) 19:10 – 19:20 Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy Michael Roden […]
Breaking the barriers: Addressing the metabolic impact of MASH with multidisciplinary care
Chairs: Irene Bretón (ESP), Helena Cortez-Pinto (PRT) 18:45 – 18:47 Introduction Irene Bretón (ESP)Helena Cortez-Pinto (PRT) 18:47 – 18:57 MASH as a metabolic disease Irene Bretón (ESP)Helena Cortez-Pinto (PRT) 18:57 – 19:07 Multidisciplinary care in MASH Irene Bretón (ESP)Helena Cortez-Pinto (PRT) 19:07 – 19:13 Q & A Irene Bretón (ESP)Helena Cortez-Pinto (PRT) 19:13 – 19:15 […]
AI-based glucose predictions – bringing diabetes self-management to the next level
15:00 – 15:30 AI-based glucose predictions – bringing diabetes self-management to the next level Pau Herrero Vinas (ESP) Nick Oliver (GBR) Thursday, 12 September 2024 15:00 – 15:30 CEST Spotlight Stage
Addressing the needs of all people living with type 1 diabetes
Chairs: Ohad Cohen (CHE), Martín Cuesta Hernandez (ESP) 12:15 – 12:30 The MiniMed™ 780G system addressing the needs of every population Martín Cuesta Hernandez (ESP) 12:30 – 12:45 The Smart MDI system: maximising the benefits of MDI therapy Peter Adolfsson (SWE) Thursday, 12 September 2024 12:15 – 12:45 CEST Spotlight Stage
From Burden to Breakthrough: Reimagining Type 1 Diabetes Treatment With Cell-Based Approaches
Chair: Stephanie Amiel (GBR) 18:45 – 18:55 Welcome and Introduction Stephanie Amiel (GBR) 18:55 – 19:15 Type 1 Diabetes Treatment in the Era of Technology: Improvements in Clinical Care and the Continuing Need for Innovation Jennifer Sherr (USA) 19:15 – 19:35 A View From the Clinic: Long-term Experience with Islet Cell Therapy for Type 1 […]
Embracing innovation in a new era of diabetes care: A CME Symposium
Chair: Tina Vilsbøll (DNK) 18:45 – 18:55 Introduction Tina Vilsbøll (DNK) 18:55 – 19:10 Current goals of type 2 diabetes treatment: Is good glycemic control enough? Kamlesh Khunti (GBR) 19:10 – 19:35 Are current strategies delivering the holistic treatment approach for people living with T2D? Melanie Davies (GBR) 19:35 – 19:55 Innovative treatment strategies: will […]
